Factors Influencing Treatment Response in Patients with Malignant Otitis Externa:

Pithiwat  Wongwan; Kanthong Thongyai; Suvajana  Atipas; Sarun  Prakairungthong; Siriporn  Limviriyakul; Kanokrat  Suvarnsit; Herman  Jenkins

doi:10.33192/smj.v77i4.272587

Authors

Pithiwat Wongwan Department of Otorhinolaryngology, Chonburi Hospital, Chonburi, Thailand
Kanthong Thongyai Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700 Thailand
Suvajana Atipas Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700 Thailand
Sarun Prakairungthong Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700 Thailand
Siriporn Limviriyakul Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700 Thailand
Kanokrat Suvarnsit Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700 Thailand
Herman Jenkins Department of Otolaryngology-Head and Neck Surgery, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA

DOI:

https://doi.org/10.33192/smj.v77i4.272587

Keywords:

Otitis externa, necrotizing otitis externa , osteomyelitis, risk factors , patient outcome assessment, Gestational Diabetes Mellitus, malignant otitis externa

Abstract

Objective: To identify factors affecting treatment outcomes in patients with malignant otitis externa (MOE).

Materials and Methods: A retrospective review of MOE treatment was conducted in patients aged > 18 years admitted to Siriraj Hospital from January 2007 to December 2022. Predictors of treatment response chosen included duration of hospitalization, duration of antimicrobial treatment, disease-related re-admissions, and mortality.

Results: The study included 49 patients (33 males, 16 females) with a mean age of 65±12 years. Comorbidities were present in 90% of patients, with diabetes mellitus being the most common. Pseudomonas aeruginosa was identified in 37% of cases. Bilateral symptoms/infections were reported in 18%. Facial nerve palsy and non-cranial nerve complications were 51% and 12%, respectively. Computed tomography (CT) imaging revealed bony erosion in 75%. Surgical management was performed in 73% of patients. The median duration of hospital stays and antimicrobial treatment were 34 days, and 143 days, respectively. Readmissions due to disease progression occurred in 35%, and the mortality rate was 4%. Bone erosion on CT was associated with an increased likelihood of readmission. Prolonged hospital stays were associated with bilateral symptoms and positive CT findings. Extended antimicrobial treatment was linked to multiple comorbidities, bilateral symptoms, non-cranial nerve complications, positive CT findings, and surgical cases.

Conclusion: Various factors influence treatment outcomes in MOE patients. Early diagnosis, aggressive treatment, and management of prognostic factors are essential for preventing severe complications and improving survival outcomes.

References

Dabholkar JP, Sheth A. Malignant otitis externa. Indian J Otolaryngol Head Neck Surg. 2001;53(1):55-6.

Treviño González JL, Reyes Suárez LL, Hernández de León JE. Malignant otitis externa: An updated review. Am J Otolaryngol. 2021;42(2):102894.

Sylvester MJ, Sanghvi S, Patel VM, Eloy JA, Ying YM. Malignant otitis externa hospitalizations: Analysis of patient characteristics. Laryngoscope. 2017;127(10):2328-36.

Slattery WH, 3rd, Brackmann DE. Skull base osteomyelitis. Malignant external otitis. Otolaryngol Clin North Am. 1996;29(5):795-806.

Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med. 1988;85(3):391-8.

Stern Shavit S, Soudry E, Hamzany Y, Nageris B. Malignant external otitis: Factors predicting patient outcomes. Am J Otolaryngol. 2016;37(5):425-30.

Hamzany Y, Soudry E, Preis M, Hadar T, Hilly O, Bishara J, et al. Fungal malignant external otitis. J Infect. 2011;62(3):226-31.

Al Aaraj MS, Kelley C. Necrotizing (Malignant) Otitis Externa. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Cecylia Kelley declares no relevant financial relationships with ineligible companies.: StatPearls Publishing

Mahdyoun P, Pulcini C, Gahide I, Raffaelli C, Savoldelli C, Castillo L, et al. Necrotizing otitis externa: a systematic review. Otol Neurotol. 2013;34(4):620-9.

Takata J, Hopkins M, Alexander V, Bannister O, Dalton L, Harrison L, et al. Systematic review of the diagnosis and management of necrotising otitis externa: Highlighting the need for high-quality research. Clin Otolaryngol. 2023;48(3):381-94.

Levenson MJ, Parisier SC, Dolitsky J, Bindra G. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO). Laryngoscope. 1991;101(8):821-4.

Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. 2007;28(6):771-3.

Glikson E, Sagiv D, Wolf M, Shapira Y. Necrotizing otitis externa: diagnosis, treatment, and outcome in a case series. Diagn Microbiol Infect Dis. 2017;87(1):74-8.

Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI. Predicting outcome of malignant external otitis. Otol Neurotol. 2008;29(3):339-43.

Chen JC, Yeh CF, Shiao AS, Tu TY. Temporal bone osteomyelitis: the relationship with malignant otitis externa, the diagnostic dilemma, and changing trends. ScientificWorldJournal. 2014;2014:591714.

Arsovic N, Radivojevic N, Jesic S, Babac S, Cvorovic L, Dudvarski Z. Malignant Otitis Externa: Causes for Various Treatment Responses. J Int Adv Otol. 2020;16(1):98-103.

Stevens SM, Lambert PR, Baker AB, Meyer TA. Malignant Otitis Externa: A Novel Stratification Protocol for Predicting Treatment Outcomes. Otol Neurotol. 2015;36(9):1492-8.

Soudry E, Joshua BZ, Sulkes J, Nageris BI. Characteristics and Prognosis of Malignant External Otitis With Facial Paralysis. Arch Otolaryngol Head Neck Surg. 2007;133(10):1002-4.

Hatch JL, Bauschard MJ, Nguyen SA, Lambert PR, Meyer TA, McRackan TR. Malignant Otitis Externa Outcomes: A Study of the University HealthSystem Consortium Database. Ann Otol Rhinol Laryngol. 2018;127(8):514-20.

Yigider AP, Ovunc O, Arslan E, Sunter AV, Cermik TF, Yigit O. Malignant Otitis Externa: How to Monitor the Disease in Outcome Estimation? Medeni Med J. 2021;36(1):23-9.

Ahmed AA, Rashid S, Gupta VK, Molony NC, Gupta KK. The diagnostic conundrum in necrotizing otitis externa. World J Otorhinolaryngol Head Neck Surg. 2024;10(1):59-65.

Kim DH, Kim SW, Hwang SH. Predictive value of radiologic studies for malignant otitis externa: a systematic review and meta-analysis. Braz J Otorhinolaryngol. 2023;89(1):66-72.

Singh J, Bhardwaj B. The Role of Surgical Debridement in Cases of Refractory Malignant Otitis Externa. Indian J Otolaryngol Head Neck Surg. 2018;70(4):549-54.

Raines JM, Schindler RA. The surgical management of recalcitrant malignant external otitis. Laryngoscope. 1980;90(3):369-78.

Chawdhary G, Pankhania M, Douglas S, Bottrill I. Current management of necrotising otitis externa in the UK: survey of 221 UK otolaryngologists. Acta Otolaryngol. 2017;137(8):818-22.